Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soheil Meshinchi

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Pediatric Clinics of North America|December 2, 2014
Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variantsKatherine Tarlock, Soheil Meshinchi
Hematology. American Society of Hematology. Education Program|December 6, 2015
Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapiesE Anders Kolb, Soheil Meshinchi
Cancer Treatment and Research|March 23, 2010
Receptor tyrosine kinase alterations in AML - biology and therapyDerek L Stirewalt, Soheil Meshinchi
The Oncologist|April 5, 2007
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemiaSoheil Meshinchi, Robert J Arceci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Structural and functional alterations of FLT3 in acute myeloid leukemiaSoheil Meshinchi, Frederick R Appelbaum
Current Hematologic Malignancy Reports|July 24, 2010
Prognostic factors in pediatric acute myeloid leukemiaMohamed Radhi, Soheil Meshinchi, Alan Gamis
Hematology. American Society of Hematology. Education Program|December 5, 2025
Using genomics to refine pediatric AML risk stratificationMartina Pigazzi, Soheil Meshinchi, Franco Locatelli
Future Oncology (London, England)|July 25, 2018
Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemiaMohammed Gbadamosi, Soheil Meshinchi, Jatinder K Lamba
Current Oncology Reports|October 3, 2003
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemiaSoheil Meshinchi, Franklin O Smith, Robert J Arceci
Blood Reviews|December 20, 2002
Molecular targets in acute myelogenous leukemiaDerek L Stirewalt, Soheil Meshinchi, Jerald P Radich
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Pediatric Clinics of North America|December 2, 2014
Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variantsKatherine Tarlock, Soheil Meshinchi
Hematology. American Society of Hematology. Education Program|December 6, 2015
Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapiesE Anders Kolb, Soheil Meshinchi
Cancer Treatment and Research|March 23, 2010
Receptor tyrosine kinase alterations in AML - biology and therapyDerek L Stirewalt, Soheil Meshinchi
The Oncologist|April 5, 2007
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemiaSoheil Meshinchi, Robert J Arceci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Structural and functional alterations of FLT3 in acute myeloid leukemiaSoheil Meshinchi, Frederick R Appelbaum
Current Hematologic Malignancy Reports|July 24, 2010
Prognostic factors in pediatric acute myeloid leukemiaMohamed Radhi, Soheil Meshinchi, Alan Gamis
Hematology. American Society of Hematology. Education Program|December 5, 2025
Using genomics to refine pediatric AML risk stratificationMartina Pigazzi, Soheil Meshinchi, Franco Locatelli
Future Oncology (London, England)|July 25, 2018
Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemiaMohammed Gbadamosi, Soheil Meshinchi, Jatinder K Lamba
Current Oncology Reports|October 3, 2003
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemiaSoheil Meshinchi, Franklin O Smith, Robert J Arceci
Blood Reviews|December 20, 2002
Molecular targets in acute myelogenous leukemiaDerek L Stirewalt, Soheil Meshinchi, Jerald P Radich
Pageof 22